Friday, 21 Sep 2018

You are here

Dr. Janet Pope: JAK 2 Inhibitor Controversy

Dr. Janet Pope talks about JAK 2 inhibitors and increased VTE as presented at the ACR/ARHP Annual Meeting in San Diego.

Add new comment

Want to talk about this video? Comment here to lead the discussion.
MORE VIDEOS

The RheumNow Week in Review – 17 May...

22 May 2017

Dr. Olga Petryna: Cardiovascular risk...

12 Jun 2017

The RheumNow Week in Review – 28 April...

30 Apr 2017

Dr. Jack Cush: The Hot Seat Cases

09 Feb 2018

Dr. Shashank Akerkar: New Molecules in...

08 Nov 2017

Week in Review - 20 Feb 2016

24 Feb 2016

Dr. Olga Petryna - Early vs. Delayed...

15 Jun 2017

Dr. Janet Pope: JAK 2 Inhibitor...

07 Nov 2017

Dr. Janet Pope: Therapy Effect on...

08 Nov 2017

The Week in Review - 11 March 2016

11 Mar 2016

RWCS 2017: Kinase Inhibitors and...

21 Feb 2017

The RheumNow Week in Review – Good News...

01 Jun 2018